Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening.

[1]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[2]  E. Sijbrands,et al.  Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study. , 2005, Atherosclerosis.

[3]  T. Leren,et al.  Cascade genetic screening for familial hypercholesterolemia , 2004, Clinical genetics.

[4]  M. Pocovi,et al.  Molecular characterization of familial hypercholesterolemia in Spain: Identification of 39 novel and 77 recurrent mutations in LDLR , 2004, Human mutation.

[5]  M. Trip,et al.  Familial hypercholesterolemia in children , 2004, Current opinion in lipidology.

[6]  H. Büller,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[7]  F. Civeira,et al.  Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. , 2004, Atherosclerosis.

[8]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[9]  A. Kessling,et al.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians , 1992, Human Genetics.

[10]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[11]  E. Sijbrands,et al.  Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children , 2003, Circulation.

[12]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[13]  E. Sijbrands,et al.  Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population , 2002, Circulation.

[14]  M. Mercuri,et al.  Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin , 2002, Circulation.

[15]  J. Viikari,et al.  Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project. , 2002, Atherosclerosis.

[16]  A. Montali,et al.  PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population , 2002, European journal of clinical investigation.

[17]  Herbert Schuster,et al.  DNA Testing for Familial Hypercholesterolemia , 2002 .

[18]  J. Kastelein,et al.  Results from a family and DNA based active identification programme for familial hypercholesterolaemia , 2001, Journal of epidemiology and community health.

[19]  J. Borén,et al.  The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100* , 2001, The Journal of Biological Chemistry.

[20]  W. Riley,et al.  Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. , 2001, The American journal of cardiology.

[21]  M. Trip,et al.  Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.

[22]  E. Sijbrands,et al.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.

[23]  I. Rabbone,et al.  Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  S. Bertolini,et al.  Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Arca,et al.  Low density lipoprotein receptor mutations in a selected population of individuals with moderate hypercholesterolemia. , 1998, Atherosclerosis.

[26]  S. Humphries,et al.  Genetic testing for familial hypercholesterolaemia: practical and ethical issues. , 1997, QJM : monthly journal of the Association of Physicians.

[27]  F. Raal,et al.  A double mutant LDL receptor allele in a Cypriot family with heterozygous familial hypercholesterolemia , 1997, Human Genetics.

[28]  I. Young,et al.  A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes. , 1996, Atherosclerosis.

[29]  S Conti,et al.  Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy. , 1995, Giornale italiano di cardiologia.

[30]  J. Viikari,et al.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene. , 1995, American journal of human genetics.

[31]  E. Levy,et al.  Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. , 1995, Pediatrics.

[32]  J. Ferrières,et al.  Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. , 1995, Circulation.

[33]  M J Malloy,et al.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.

[34]  J. Cortner,et al.  Prevalence and expression of familial combined hyperlipidemia in childhood. , 1990, The Journal of pediatrics.

[35]  M. Kotze,et al.  The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia. , 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[36]  H. Mabuchi,et al.  Development of coronary heart disease in familial hypercholesterolemia. , 1989, Circulation.

[37]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[38]  R. Levy,et al.  Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. , 1974, The Journal of clinical investigation.

[39]  T. Miettinen,et al.  Comparison of clinical findings in patients with hyperglyceridaemia and familial hypercholesterolaemia. , 1973, Annals of clinical research.